Abstracts The coronavirus disease 2019 (COVID-19) affects infected patients even after the
acute phase and impairs their health and quality of life by causing a wide variety of …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), could affect brain structure and function. SARS-CoV …

ABSTRACT Introduction Post-COVID syndrome (PCS) is recognized as a new entity in the
context of SARS-CoV-2 infection. Though its pathogenesis is not completely understood …

With the decline in the number of new Severe Acute Respiratory Syndrome Coronavirus 2
(SARS‐CoV‐2) infections, the World Health Organization announced the end of the SARS …

Clinical sequelae and symptoms for a considerable number of COVID-19 patients can linger
for months beyond the acute stage of SARS-CoV-2 infection,“long COVID”. Among the long …

Simple Summary Although SARS-CoV-2 primarily affects the upper respiratory system and
the lungs, it can also affect vasculature, leading to the impairment of endothelial and multi …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a newly emerged
coronavirus, has sparked a global pandemic with its airborne transmission and ability to …

Background In coronavirus disease (COVID-19), physical capacity is one of the most
impaired sequelae. Due to their simplicity and low cost, field tests such as the six-minute …

Several reports have shown that the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has the potential to also be neurotropic. However, the mechanisms by which …

Severe acute respiratory syndrome coronavirus type 2 (SARS‐CoV‐2) is the causative
agent of coronavirus disease 2019 (COVID‐19). In less than three years, an estimated 600 …